DBV Technologies SA - American share price logo

DBV Technologies SA - American

NASDAQ: DBVT

Small Cap

$10.44

-0.11

(-1.04%)

as on

DBV Technologies SA - American Stock Performance

as on October 6, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $10.24
    $10.74
    downward going graph

    1.92%

    Downside

    2.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $10.23
    $26.19
    downward going graph

    2.01%

    Downside

    150.81%

    Upside

    downward going graph

DBV Technologies SA - American share price movements today

Previous Close
$10.55
Open
$10.31
Volume
730.4K
Market Cap
$663.1M
Day's Low - High
$10.24 - $10.74
52 Week Low - High
$10.23 - $26.19

DBV Technologies SA - American Historical Returns

1 Month Return
-22.49 %
3 Month Return
-33.12 %
1 Year Return
-21.44 %
3 Year Return
-13 %
5 Year Return
-77.74 %

DBV Technologies SA - American Stock Fundamentals & Key Indicators

Check DBV Technologies SA - American market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$663.1M

EPS (TTM)

-1.98

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.75

Industry PE ratio

-6.24

PEG Ratio

-0.07

EBITDA

-172.3M

Revenue (TTM)

-

Profit Margin

-122.19%

Return On Equity TTM

-119.47%

DBV Technologies SA - American vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of DBV Technologies SA - American with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$663.1M-77.74%-2.75-122.19%0.00%
StrongBuy$44.3B650.56%-23.320.00%0.00%
Neutral$75.9B-32.81%-23.81-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B32.91%17.5584.86%0.50%

Stock Returns calculator for DBV Technologies SA - American Stock including INR - Dollar returns

The DBV Technologies SA - American stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

DBV Technologies SA - American investment value today

Current value as on today

₹85,372

Returns

-₹14,628

(-14.63%)

Returns from DBV Technologies SA - American Stock

-₹21,445 (-21.44%)

Dollar Impact

₹6,817 (+6.82%)

Analyst Recommendation on DBV Technologies SA - American Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for DBV Technologies SA - American. Average target price of $38.79

DBV Technologies SA - American Share Price Target

Get share price movements and forecasts by analysts on DBV Technologies SA - American.

What analysts predicted

73.09%UPSIDE

Target Price

$38.79

Current Price

$10.44

Analyzed by

4 Analysts

High

$51

Target

$38.79

Low

$40

DBV Technologies SA - American target price $38.79, a slight upside of 73.09% compared to current price of $10.44. According to 4 analysts rating.

Indian Investors' Interest in DBV Technologies SA - American Stock

Search interest for DBV Technologies SA - American Stock has increased by 112% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:112% versus previous 30 day period

DBV Technologies SA - American Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
-
1
0
-
-
-
-
-
-
Gross Profit
1
-4
1
0
-
-4
-4
-
-
-
Operating Income
-28
-34
-30
-23
-26
-43
-36
-45
-47
-51
EBITDA
-26
-30
-28
-23
-25
-38
-31
-43
-45
-51
Interest Expense
-
-
0
-
0
0
-
-
-
-
Depreciation
2
4
1
0
1
4
4
1
2
-
Income Before Tax
-27
-34
-30
-23
-27
-43
-35
-44
-47
-51
Income Tax Expense
0
-1
-
0
0
-1
-2
0
0
0
Net Income
-27
-33
-30
-23
-27
-42
-33
-44
-47
-50
Net Profit Margin
100.00%
0.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

DBV Technologies SA - American Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
11
12
14
11
5
4
15
-
-
Gross Profit
11
12
14
11
-4
4
15
-6
-
Operating Income
-173
-190
-171
-158
-98
-96
-76
-120
-147
EBITDA
-176
-206
-168
-124
-91
-83
-63
-110
-139
Interest Expense
3
0
0
0
0
-
-
-
-
Depreciation
3
3
2
10
8
13
13
6
7
Income Before Tax
-177
-190
-171
159
-98
-96
-72
-117
-146
Income Tax Expense
0
0
0
0
0
0
0
-4
0
Net Income
-177
-190
-172
-159
-97
-96
-72
-113
-146
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
-62.46%
-322.90%
100.00%
0.00%
0.00%

DBV Technologies SA - American Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-27
-33
-30
-23
-27
-41
-33
-44
-47
-70
Operating Cash Flow
-34
-35
-22
-12
-19
-33
-32
-35
-49
-83
Investing Cash Flow
-2
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
116
0
159
88
88
Change in Cash
-39
-35
-19
-13
-19
90
-33
124
35
0

DBV Technologies SA - American Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-207
-227
-172
-159
-97
-96
-72
-113
-146
Operating Cash Flow
-160
-186
-148
-165
-108
-55
-79
-104
-121
Investing Cash Flow
-11
-11
-5
-2
0
0
0
0
-1
Financing Cash Flow
0
178
207
149
0
194
6
0
276
Change in Cash
-166
-20
52
3
-119
131
-67
-108
161

Global Institutional Holdings in DBV Technologies SA - American

Check out the Institutions with significant holdings in DBV Technologies SA - American.

Funds
Holdings
Joseph Edelman
2.63%
Felix Baker
2.32%
Artisan Partners Funds Inc.
2.17%
Stanley Druckenmiller
0.61%
RUSSELL INVESTMENT CO
0.11%

DBV Technologies SA - American News & Key Events

  • img

    Today's Timeline - 17 December

    Wed, 02:38 PM

    -

    DBV Technologies announces positive Phase 3 trial results for Viaskin Peanut patch, meeting primary endpoint for peanut allergies in children.

Insights on DBV Technologies SA - American

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 637.9% return, outperforming this stock by 659.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 95.6% return, outperforming this stock by 108.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 8.87M → 511.0K (in $), with an average decrease of 40.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -33.01M → -50.4M (in $), with an average decrease of 16.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, DBVT stock has moved down by -9.6%

About DBV Technologies SA - American

DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase III clinical trials as an immunotherapy for peanut allergies in children aged 4 to 11, adolescents, and adults. The company's pipeline also includes Viaskin Milk, currently undergoing Phase I/II clinical trials for the treatment of Immunoglobulin E (IgE)-mediated cow's milk protein allergy, and Viaskin Egg, which is in pre-clinical development for hen's egg allergy. Additionally, DBV Technologies is developing a booster vaccine targeting Bordetella pertussis. Beyond these, the company explores earlier-stage research for a respiratory syncytial virus vaccine and potential therapies for Crohn's disease, celiac disease, and type I diabetes. In partnership with Nestlé Health Science, it is developing MAG1C, a user-friendly atopy patch test for diagnosing non-IgE mediated cow's milk protein allergy in infants and toddlers. DBV Technologies S.A. was established in 2002.
OrganisationDBV Technologies SA - American
HeadquartersBAtiment IRO, Châtillon, 92320, FR
IndustryBiotechnology
CEODaniel Tassé

Key Management of DBV Technologies SA - American

Name

Title

Mr. Daniel Tassé

CEO & Director

Dr. Pharis Mohideen M.D.

Chief Medical Officer

Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.

Chief Operations Officer

Mr. Jonathan Neely

VP & Head of Investor Relations

Alan Kerr

Senior VP & Head of Global Regulatory Affairs

Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.

Chief Financial Officer

Ms. Michele F. Robertson

Chief Legal Officer

Mr. James Briggs

Chief Human Resources Officer

Mr. Kevin Trapp

Chief Commercial Officer

Mr. Pascal Wotling

Chief External Manufacturing & Supply Chain Officer

FAQs

What is DBV Technologies SA - American share price today?

DBV Technologies SA - American share price today is $10.44 as on at the close of the market. DBV Technologies SA - American share today touched a day high of $10.74 and a low of $10.24.

What is the 52 week high and 52 week low for DBV Technologies SA - American share?

DBV Technologies SA - American share touched a 52 week high of $26.19 on and a 52 week low of $10.23 on . DBV Technologies SA - American stock price today i.e. is closed at $10.44,which is 60.13% down from its 52 week high and 2.05% up from its 52 week low.

What is DBV Technologies SA - American's market capitalisation today?

DBV Technologies SA - American market capitalisation is $0.00T as on .

How to invest in DBV Technologies SA - American Stock (DBVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for DBV Technologies SA - American on INDmoney app. Click on Buy button.

What is the minimum amount required to buy DBV Technologies SA - American Stock (DBVT) from India?

Indian investors can start investing in DBV Technologies SA - American (DBVT) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in DBV Technologies SA - American stock (as per the Rupee-Dollar exchange rate as on ). Based on DBV Technologies SA - American share’s latest price of $10.44 as on October 6, 2026 at 8:45 am IST, you will get 0.9579 shares of DBV Technologies SA - American. Learn more about fractional shares .

What are the returns that DBV Technologies SA - American has given to Indian investors in the last 5 years?

DBV Technologies SA - American stock has given -77.74% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?